{"podcast":{"title":"Health News Today | 2 Min News | The Daily News Now!","slug":"health-news-today-2-min-news-the-daily-news-now-7685759","podcast_index_feed_id":7685759,"rss_url":"https://feeds.fastcast.ai/health-and-fitness-news-today-2-min-news-the-daily-news-now.xml","website_url":null,"image_url":"https://image.fastcast.ai/cover/01017222-be18-4060-a2b6-ae821dbc23fa.png","author":"The Daily News Now!","episode_count":268,"summary":"Hosted by Corey with the Story, Health and Fitness News Today delivers fast, focused daily updates on the stories shaping health, wellness, and performance—from fitness trends and nutrition to medical breakthroughs and lifestyle insights. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—covering the topics that impact your everyday life and keeping you informed. Health and Fitness News Today is your daily snapshot of what’s happening in health and wellness. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-26T00:19:56.628058+00:00","page_url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759"},"episode":{"title":"Fixed-Duration Therapy Changes CLL Treatment | Health and Fitness News","slug":"fixed-duration-therapy-changes-cll-treatment-health-and-fitness-news","published_at":"2026-07-18T05:12:12+00:00","page_url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759/fixed-duration-therapy-changes-cll-treatment-health-and-fitness-news","show_page_url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759","url":"https://sources.thednn.ai/1586df6d377e9fd5","audio_url":"https://api.fastcast.ai/audio/915bb52a-16f0-44a3-b2ac-ddfdb625f2aa.mp3","summary":"CLL treatment is undergoing a major shift with fixed-duration therapy—patients now take meds for a set time (usually 1-2 years) instead of lifelong treatment, offering a clear endpoint, fewer side effects, and potentially delaying drug resistance. While promising, it’s not for all—doctors evaluate genetic markers to determine eligibility, and drugs like venetoclax require close monitoring. Common regimens combine venetoclax with monoclonal antibodies or BTK inhibitors, lasting 12-14 months, with ongoing research expanding options. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/1586df6d377e9fd5","meta_description":"CLL treatment is undergoing a major shift with fixed-duration therapy—patients now take meds for a set time (usually 1-2 years) instead of lifelong treatm…","key_points":[],"chapters":[],"topics":[],"duration_seconds":119,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/health-news-today-2-min-news-the-daily-news-now-7685759/episodes/fixed-duration-therapy-changes-cll-treatment-health-and-fitness-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759/fixed-duration-therapy-changes-cll-treatment-health-and-fitness-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}